Tower Bridge Advisors Novartis Ag Transaction History

Tower Bridge Advisors

  • $900 Billion
  • Q2 2024

A detailed history of Tower Bridge Advisors transactions in Novartis Ag stock. As of the latest transaction made, Tower Bridge Advisors holds 83,362 shares of NVS stock, worth $9.72 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
83,362
Previous 84,968 1.89%
Holding current value
$9.72 Million
Previous $8.22 Billion 7.98%
% of portfolio
0.99%
Previous 0.84%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024
SELL
$92.57 - $107.37 $148,667 - $172,436
-1,606 Reduced 1.89%
83,362 $8.87 Billion
Q1 2024

Apr 29, 2024
SELL
$95.27 - $108.47 $575,621 - $655,375
-6,042 Reduced 6.64%
84,968 $8.22 Billion
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $98,544 - $108,444
-1,068 Reduced 1.16%
91,010 $9.19 Billion
Q3 2023

Nov 01, 2023
SELL
$94.73 - $105.13 $107,139 - $118,902
-1,131 Reduced 1.21%
92,078 $9.38 Billion
Q2 2023

Jul 20, 2023
SELL
$92.52 - $104.91 $1.15 Million - $1.31 Million
-12,440 Reduced 11.77%
93,209 $9.41 Billion
Q1 2023

Apr 26, 2023
SELL
$80.03 - $92.81 $197,754 - $229,333
-2,471 Reduced 2.29%
105,649 $9.72 Billion
Q4 2022

Jan 27, 2023
SELL
$75.55 - $92.52 $191,141 - $234,075
-2,530 Reduced 2.29%
108,120 $9.81 Billion
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $223,307 - $261,169
-2,993 Reduced 2.63%
110,650 $8.41 Billion
Q2 2022

Jul 21, 2022
SELL
$80.52 - $93.75 $122,873 - $143,062
-1,526 Reduced 1.33%
113,643 $9.61 Billion
Q1 2022

May 05, 2022
SELL
$80.11 - $90.62 $315,713 - $357,133
-3,941 Reduced 3.31%
115,169 $10.1 Billion
Q4 2021

Feb 09, 2022
SELL
$79.7 - $88.13 $1.43 Million - $1.58 Million
-17,984 Reduced 13.12%
119,110 $10.4 Billion
Q3 2021

Oct 28, 2021
SELL
$81.78 - $95.14 $208,293 - $242,321
-2,547 Reduced 1.82%
137,094 $11.2 Billion
Q2 2021

Aug 10, 2021
SELL
$85.24 - $94.15 $216,850 - $239,517
-2,544 Reduced 1.79%
139,641 $12.7 Billion
Q1 2021

May 12, 2021
SELL
$83.5 - $98.47 $274,130 - $323,277
-3,283 Reduced 2.26%
142,185 $12.2 Billion
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $229,916 - $278,096
2,945 Added 2.07%
145,468 $13.7 Billion
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $303,343 - $336,063
3,693 Added 2.66%
142,523 $12.4 Billion
Q2 2020

Jul 22, 2020
BUY
$80.93 - $91.1 $688,390 - $774,896
8,506 Added 6.53%
138,830 $12.1 Billion
Q1 2020

Apr 27, 2020
BUY
$70.67 - $99.01 $675,393 - $946,238
9,557 Added 7.91%
130,324 $10.7 Billion
Q4 2019

Feb 05, 2020
BUY
$84.35 - $95.37 $594,498 - $672,167
7,048 Added 6.2%
120,767 $11.4 Billion
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $207,434 - $228,580
2,425 Added 2.18%
113,719 $10 Billion
Q2 2019

Aug 06, 2019
BUY
$75.4 - $92.8 $21,866 - $26,912
290 Added 0.26%
111,294 $10.2 Billion
Q1 2019

Apr 30, 2019
BUY
$75.32 - $86.15 $47,074 - $53,843
625 Added 0.57%
111,004 $10.7 Billion
Q4 2018

Feb 07, 2019
BUY
$73.66 - $82.02 $10,238 - $11,400
139 Added 0.13%
110,379 $9.47 Billion
Q3 2018

Oct 23, 2018
BUY
$66.94 - $77.43 $324,324 - $375,148
4,845 Added 4.6%
110,240 $9.5 Billion
Q2 2018

Aug 09, 2018
SELL
$64.91 - $73.36 $256,654 - $290,065
-3,954 Reduced 3.62%
105,395 $7.96 Billion
Q1 2018

May 02, 2018
BUY
$70.39 - $84.15 $361,734 - $432,446
5,139 Added 4.93%
109,349 $8.84 Billion
Q4 2017

Jan 30, 2018
BUY
$72.33 - $77.64 $385,952 - $414,287
5,336 Added 5.4%
104,210 $8.75 Billion
Q3 2017

Nov 06, 2017
BUY
$74.14 - $77.27 $7.33 Million - $7.64 Million
98,874
98,874 $8.49 Billion

Others Institutions Holding NVS

# of Institutions
1,425
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $251B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Tower Bridge Advisors Portfolio

Follow Tower Bridge Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Bridge Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Tower Bridge Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email